These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35489474)

  • 21. High-Surety Isothermal Amplification and Detection of SARS-CoV-2.
    Bhadra S; Riedel TE; Lakhotia S; Tran ND; Ellington AD
    mSphere; 2021 May; 6(3):. PubMed ID: 34011690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A sample-to-answer, quantitative real-time PCR system with low-cost, gravity-driven microfluidic cartridge for rapid detection of SARS-CoV-2, influenza A/B, and human papillomavirus 16/18.
    Zai Y; Min C; Wang Z; Ding Y; Zhao H; Su E; He N
    Lab Chip; 2022 Sep; 22(18):3436-3452. PubMed ID: 35972195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging ultrafast nucleic acid amplification technologies for next-generation molecular diagnostics.
    Lee SH; Park SM; Kim BN; Kwon OS; Rho WY; Jun BH
    Biosens Bioelectron; 2019 Sep; 141():111448. PubMed ID: 31252258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection.
    Fujiya Y; Sato Y; Katayama Y; Nirasawa S; Moriai M; Saeki M; Yakuwa Y; Kitayama I; Asanuma K; Kuronuma K; Takahashi S
    J Infect Chemother; 2022 Nov; 28(11):1590-1593. PubMed ID: 35953013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative comparison of SARS-CoV-2 nucleic acid amplification test and antigen testing algorithms: a decision analysis simulation model.
    Salvatore PP; Shah MM; Ford L; Delaney A; Hsu CH; Tate JE; Kirking HL
    BMC Public Health; 2022 Jan; 22(1):82. PubMed ID: 35027019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus.
    Zhuang QZ; Li ZZ; Chao Y; Li F; Ge YY; Sha YH; Wang Y; Huang XZ; Ke PF; Xiong YJ
    Clin Lab; 2021 Jul; 67(7):. PubMed ID: 34258963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isothermal amplification-based assays for rapid and sensitive detection of severe acute respiratory syndrome coronavirus 2: Opportunities and recent developments.
    Maiti B; Anupama KP; Rai P; Karunasagar I; Karunasagar I
    Rev Med Virol; 2022 Mar; 32(2):e2274. PubMed ID: 34216498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isothermal amplification-assisted diagnostics for COVID-19.
    De Felice M; De Falco M; Zappi D; Antonacci A; Scognamiglio V
    Biosens Bioelectron; 2022 Jun; 205():114101. PubMed ID: 35202984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CASCADE: Naked eye-detection of SARS-CoV-2 using Cas13a and gold nanoparticles.
    López-Valls M; Escalona-Noguero C; Rodríguez-Díaz C; Pardo D; Castellanos M; Milán-Rois P; Martínez-Garay C; Coloma R; Abreu M; Cantón R; Galán JC; Miranda R; Somoza Á; Sot B
    Anal Chim Acta; 2022 May; 1205():339749. PubMed ID: 35414398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Considerations regarding Interpretation of Positive SARS-CoV-2 Molecular Results with Late Cycle Threshold Values.
    Mitchell SL; Loeffelholz MJ
    J Clin Microbiol; 2022 Sep; 60(9):e0050122. PubMed ID: 35658526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A precise review on NAATs-based diagnostic assays for COVID-19: A motion in fast POC molecular tests.
    Maleki B; Hojati Z
    Eur J Clin Invest; 2022 Nov; 52(11):e13853. PubMed ID: 35989561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rolling Circle Amplification in Integrated Microsystems: An Uncut Gem toward Massively Multiplexed Pathogen Diagnostics and Genotyping.
    Soares RRG; Madaboosi N; Nilsson M
    Acc Chem Res; 2021 Nov; 54(21):3979-3990. PubMed ID: 34637281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point-of-care nucleic acid testing for infectious diseases.
    Niemz A; Ferguson TM; Boyle DS
    Trends Biotechnol; 2011 May; 29(5):240-50. PubMed ID: 21377748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for Engineering Affordable Technologies for Point-of-Care Diagnostics of Infectious Diseases.
    Zamani M; Furst AL; Klapperich CM
    Acc Chem Res; 2021 Oct; 54(20):3772-3779. PubMed ID: 34612619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital.
    Hohl CM; Hau JP; Vaillancourt S; Grant J; Brooks SC; Morrison LJ; Perry JJ; Rosychuk RJ;
    JAMA Netw Open; 2022 Oct; 5(10):e2236288. PubMed ID: 36223119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between nucleic acid amplification tests, antigen immunofluorescence assay, and in vitro infectivity in SARS-CoV-2 diagnosis.
    Zupin L; Fontana F; Clemente L; Ruscio M; Crovella S
    Braz J Microbiol; 2022 Sep; 53(3):1271-1277. PubMed ID: 35446012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrated rapid nucleic acid detection assay based on recombinant polymerase amplification for SARS-CoV-2.
    Tang Y; Wang Y; Li Y; Zhao H; Zhang S; Zhang Y; Li J; Chen Y; Wu X; Qin C; Jiang T; Kang X
    Virol Sin; 2022 Feb; 37(1):138-141. PubMed ID: 35234627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR Cas12a-enabled biosensors coupled with commercial pregnancy test strips for the visible point-of-care testing of SARS-CoV-2.
    Shen P; Si Z; Huang D; Xu Z; Wang Z; Fang M; Xu Z
    Analyst; 2023 May; 148(11):2573-2581. PubMed ID: 37159023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three SARS-CoV-2 PCR-negative cases of COVID-19 diagnosed using isothermal amplification methods.
    Shinozawa S; Moriyama Y
    J Infect Chemother; 2022 Jul; 28(7):1005-1007. PubMed ID: 35430091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.